Navigation Links
New nanoparticles could revolutionize therapeutic drug discovery
Date:6/25/2009

A revolutionary new protein stabilisation technique has been developed by scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) which could lead to 30 per cent more proteins being available as potential targets for drug development - opening up exciting possibilities in drug discovery.

Understanding the structure of proteins is a vital first step in developing new drugs, but to date, drug development has been slowed because due to their instability, proteins are difficult to work with in lab conditions. However, using nanoparticles, scientists from the Universities of Birmingham and Warwick have found a way to preserve membrane proteins intact, enabling detailed analysis of their structure and molecular functions.

These new findings, which have just been published online in the Journal of the American Chemical Society, will give scientists access to previously ignored proteins deemed too unstable to work with.

Professor Michael Overduin, from the University of Birmingham, who led the study, explained: "We have shown how a polymer can wrap around and preserve membrane proteins intact in stable nanoparticles. Membrane proteins are the most valuable but technically challenging targets for drug discovery. Finding a gentle solution that preserves their structure and activity, yet is robust enough for experimental interrogation, has eluded scientists for decades, but is now available."

Using a polymer - styrene maleic acid lipid particles (SMALPs), the researchers solubilised a pair of membrane proteins. They found that not only did the proteins maintain their folded structure, binding and enzyme activities in the SMALPs, but also that using the nanoparticles allowed them to be simply and rapidly used for virtually any laboratory analysis.

Advantages of SMALPs over traditional ways to solubilise proteins such as detergents include enhanced stability, activity and spectral quality of the protein membranes.

Dr Tim Dafforn who jointly ran the study, said: "In the past, studies have concentrated largely on soluble proteins as membrane proteins are so difficult to make. However, the discovery of the SAMLPs removes this barrier and opens up access to membrane proteins - this has exciting clinical implications as it may enable drug discovery on receptors that are currently too difficult to produce or study by current methods."

Commenting on the findings, BBSRC Chief Executive Professor Doug Kell, said: "The attrition rate in developing new drugs is phenomenal. Only a tiny fraction make it into the clinic to benefit patients. Research such as this that can help to increase the number of potential targets will mean a larger pipeline for scientists to develop new drugs from and, ultimately more, better drugs for patients. Fundamental bioscience working in coordination with medical research is vital to deliver new, effective drugs."


'/>"/>

Contact: Matt Goode
press.office@bbsrc.ac.uk
44-179-341-4694
Biotechnology and Biological Sciences Research Council
Source:Eurekalert

Related biology news :

1. Shape matters in the case of cobalt nanoparticles
2. To fight drug addiction, UB researchers target the brain with nanoparticles
3. Magnetic nanoparticles navigate therapeutic genes through the body
4. The gold standard: Biodesign Institute researchers use nanoparticles to make 3-D DNA nanotubes
5. Nanoparticles in the home: More and smaller than previously detected
6. UD researchers show that plants can accumulate nanoparticles in tissues
7. Workshop on environmental nanoparticles at UD, Nov. 10-11
8. MU scientists go green with gold, distribute environmentally friendly nanoparticles
9. $2M grant awarded to University of Kentucky for research on nanoparticles and human health
10. New ORNL process brings nanoparticles into focus
11. Nanoparticles assemble by millions to encase oil drops
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2018)... , ... September 20, 2018 , ... ... version of NovoExpress® software which supports the recently launched NovoCyte ... NovoCyte® flow cytometer and NovoSampler® Pro products. , In addition ...
(Date:9/15/2018)... Wis. (PRWEB) , ... September 14, 2018 , ... The ... the rate of clearance of green, blue, and purple tattoo inks - often the ... Surgery and Medicine (LSM), the official journal of the American Society for Laser Medicine ...
(Date:9/12/2018)... ... September 12, 2018 , ... ... education, is pleased to support the professional development of academic librarians by sponsoring ... , The entrants were asked to submit successful strategies to increase collaboration among ...
Breaking Biology News(10 mins):
(Date:9/12/2018)... ... September 11, 2018 , ... Leading regenerative ... of Feline Practitioners Conference (AAFP) later this month. The company’s CEO ... therapy for the treatment of chronic kidney disease in felines at a poster ...
(Date:9/12/2018)... ... 12, 2018 , ... NDA Partners Chairman Carl Peck, MD, ... of Regulatory Affairs and Quality Systems at WellDoc, Inc., has joined the firm ... Quality Systems at WellDoc, Inc., she conducted quality control and supplier audits, led ...
(Date:9/7/2018)... ... 06, 2018 , ... The Discovery on Target (DOT) conference ... industry’s preeminent event on novel drug targets.” BellBrook Labs’ high throughput screening (HTS) ... emerging targets in a quest to find new treatments for disease. , BellBrook ...
(Date:9/7/2018)... ... 2018 , ... Flagship Biosciences’ MuscleMap algorithm that supports therapeutic ... effective as manual pathology. The study, “Validation of a Muscle-Specific Tissue Image-Analysis Tool ... the Archives of Pathology & Laboratory Medicine on August 31, 2018. Download the ...
Breaking Biology Technology: